8-Mar-2018 12:05 PM EST
Yale Cancer Center
Add to Favorites
Daniel P. Petrylak, MD, regarding PD-L1 biomarkers in the treatment of bladder cancer
Available for logged-in reporters only
Daniel P. Petrylak, MDProfessor of Medicine (Medical Oncology) and of Urology; Co-Director, Signal Transduction Research Program
Available at 203.785.2815 or firstname.lastname@example.org
Leave a comment...